RHUMBLINE ADVISERS - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 97 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$1,571,000
-46.8%
77,944
-1.4%
0.00%
-50.0%
Q2 2021$2,951,000
+38.7%
79,063
-5.0%
0.00%
+33.3%
Q1 2021$2,128,000
+8.7%
83,217
-6.3%
0.00%0.0%
Q4 2020$1,957,000
+21.0%
88,831
-1.2%
0.00%0.0%
Q3 2020$1,618,000
-38.0%
89,934
-12.4%
0.00%
-25.0%
Q2 2020$2,609,000
+83.3%
102,697
+32.6%
0.00%
+33.3%
Q1 2020$1,423,000
-13.7%
77,443
+3.5%
0.00%0.0%
Q4 2019$1,648,000
+57.9%
74,804
+2.9%
0.00%
+50.0%
Q3 2019$1,044,000
-8.2%
72,690
+0.7%
0.00%0.0%
Q2 2019$1,137,000
+10.7%
72,163
+3.0%
0.00%0.0%
Q1 2019$1,027,000
+43.0%
70,078
+4.3%
0.00%0.0%
Q4 2018$718,000
+15.6%
67,192
+65.1%
0.00%
+100.0%
Q3 2018$621,000
+19.0%
40,709
-4.4%
0.00%0.0%
Q2 2018$522,000
+569.2%
42,601
+194.6%
0.00%
Q1 2016$78,000
-54.7%
14,4630.0%0.00%
-100.0%
Q4 2015$172,000
+59.3%
14,463
+10.3%
0.00%
Q3 2015$108,000
-38.3%
13,108
+4.7%
0.00%
-100.0%
Q2 2015$175,00012,5150.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,705,392$43,607,0007.88%
Bain Capital Life Sciences Investors, LLC 3,080,237$78,762,0004.46%
DAFNA Capital Management LLC 587,756$15,029,0003.57%
RTW INVESTMENTS, LP 7,463,291$190,836,0002.98%
SILVERARC CAPITAL MANAGEMENT, LLC 200,000$5,114,0002.79%
Evolutionary Tree Capital Management, LLC 122,473$3,132,0001.85%
Parkman Healthcare Partners LLC 303,268$7,755,0001.80%
Eagle Health Investments LP 161,125$4,120,0001.62%
BRIDGER MANAGEMENT, LLC 588,910$15,058,0001.41%
Woodline Partners LP 1,777,000$45,438,0001.01%
View complete list of DICERNA PHARMACEUTICALS INC shareholders